Innovation Pharmaceuticals Inc. (9)
Browse by Contract Category
Contracts
-
Securities Purchase Agreement, dated December 9, 2020, between the Company and the investor party thereto
(Filed With SEC on December 10, 2020)
-
Exclusive License Agreement, dated July 18, 2019, between Innovation Pharmaceuticals Inc. and Alfasigma S.p.A
(Filed With SEC on July 22, 2019)
-
Form of Warrant
(Filed With SEC on December 10, 2020)
-
Common Stock Purchase Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC
(Filed With SEC on August 4, 2020)
-
Registration Rights Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC
(Filed With SEC on August 4, 2020)
-
Form of Warrant Amendment Agreement, dated December 26, 2019, between the Company and each investor party thereto
(Filed With SEC on December 26, 2019)
-
Description of Class A common stock
(Filed With SEC on September 30, 2019)
-
Form of Series 4 Warrant
(Filed With SEC on May 10, 2019)
-
Form of Warrant Restructuring and Additional Issuance Agreement, dated May 9, 2019, between the Company and the investors party thereto
(Filed With SEC on May 10, 2019)